
New onset of Juvenile Dermatomyositis during Tumor Necrosis Factor Inhibitor (Adalimumab) Therapy
Author(s) -
SunilV Kapur,
JitendraS Oswal
Publication year - 2022
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.4103/injr.injr_266_20
Subject(s) - medicine , juvenile dermatomyositis , adalimumab , dermatomyositis , tumor necrosis factor α , tumor necrosis factor alpha , dermatology